Cryo-Cell International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cryo-Cell International generated cash of $8,919,754, which is more than the previous year. Cash used in financing activities reached the amount of -$2,072,891 last year. Net change in cash is therefore -$1,297,891.
Cash Flow
| 2014 | 1.55M | 391.20K | -2.59M |
|---|---|---|---|
| 2015 | 4.85M | -719.34K | -3.25M |
| 2016 | 4.98M | -369.72K | -5.27M |
| 2017 | 5.71M | 93.02K | -3.03M |
| 2018 | 5.33M | -11.28M | 5.70M |
| 2019 | 6.32M | -690.65K | -5.13M |
| 2020 | 8.46M | 357.48K | -5.00M |
| 2021 | 7.92M | -6.95M | -3.07M |
| 2022 | 8.57M | -15.27M | 147.86K |
| 2023 | 8.91M | -8.14M | -2.07M |
CCEL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.70M | 8.26M | 10.36M | 6.54M | 6.04M | 6.27M | 3.49M | 4.15M | 3.27M | 3.92M |
Operating activities | ||||||||||
Net income | -9.52M | 2.77M | 2.08M | 3.62M | 2.29M | -854.82K | 2.31M | -1.32M | 8.10M | 553.62K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.71M | 1.80M | 1.32M | 635.97K | 401.31K | 317.32K | 229.99K | 286.65K | 241.20K | 377.00K |
Stock-based compensation expense | 816.63K | 461.34K | 301.61K | 622.12K | 397.77K | 0 | 971.73K | 1.77M | 602.97K | 404.23K |
| Deferred income tax benefit | 816.63K | 461.34K | 301.61K | 622.12K | 397.77K | 0 | 971.73K | 1.77M | 602.97K | 404.23K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 6.57M | -1.72M | 532.78K | -828.59K | -997.12K | -1.34M | -1.14M | -1.62M | 313.93K | -2.03M |
Inventories | 0 | 490.00K | 210.27K | 454.94K | -27.42K | 316.65K | 46.57K | 114.46K | 117.23K | 70.38K |
Accounts payable | 0 | 115.52K | 532.38K | -411.72K | 107.45K | -666.88K | 443.11K | 329.56K | 335.70K | -201.91K |
Cash generated by operating activities | 8.91M | 8.57M | 7.92M | 8.46M | 6.32M | 5.33M | 5.71M | 4.98M | 4.85M | 1.55M |
Investing activities | ||||||||||
Purchases Of Investments | -1.08M | -1.14M | 0 | 0 | -28.36K | 0 | 0 | 0 | 0 | -64.76K |
Investments In Property Plant And Equipment | -6.83M | -17.16M | -6.95M | -449.96K | -662.29K | -646.16K | -98.33K | -342.98K | -108.48K | -120.51K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -10.5M | 0 | 0 | -375.37K | -187.5K |
Cash generated by investing activities | -8.14M | -15.27M | -6.95M | 357.48K | -690.65K | -11.28M | 93.02K | -369.72K | -719.34K | 391.20K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | -7.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -799.03K | -1.81M | -249.37K | 0 | -992.24K | 0 | -446.62K | -10.80M | -3.20M | -2.67M |
Repayments of term debt | -1.20M | 9.28M | -4.1M | -3.1M | -4.1M | -3.29M | -2.65M | -1.50M | -123.63K | 0 |
Cash used in financing activities | -2.07M | 147.86K | -3.07M | -5.00M | -5.13M | 5.70M | -3.03M | -5.27M | -3.25M | -2.59M |
Net Change In Cash | -1.29M | -6.55M | -2.09M | 3.82M | 501.00K | -239.12K | 2.77M | -652.28K | 872.89K | -645.88K |
Cash at end of period | 406.06K | 1.70M | 8.26M | 10.36M | 6.54M | 6.04M | 6.27M | 3.49M | 4.15M | 3.27M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |